|Day Low/High||40.94 / 41.00|
|52 Wk Low/High||31.43 / 48.25|
As health-care stocks rally, it's time for politicians to move on.
Deals coming fast and furious in the best group in town.
Whether it's acquiring or the acquired, Mylan is building shareholder value.
Americans are living much longer these days -- and there are a number of ways to invest.
On Wednesday, October 22nd we continue a busy earnings week, with the country's second largest wireless carrier, AT&T Inc.
Federal Reserve Bank of New York, Goldman Sachs, secretly recorded tapes, and a female employee fired -- those are all real life elements from the headlines circulating around Carmen Segarra.
McDonald's and GlaxoSmithKline are fighting against major turns of the tide.
Investors will be tracking Pfizer's earnings when they report first-quarter results on May 5. Expectations are for earnings of $0.55 a share on sales of $12.07 billion.
Medidata Solutions is focusing its cloud-computing offerings on the pharmaceutical industry.
Johnson & Johnson replaces Merck in AAP given better pipeline and stock upside potential, says AAP Co-Portfolio Manager, Stephanie Link.
U.S. stock futures are pointing to a higher open as Obama presses case for military action in Syria.
GlaxoSmithKline revealed that some of its senior executives in China may have broken the law.
Jim Cramer and Stephanie Link, Co-Portfolio Managers of AAP, discuss how they are trading the current bull market.
Luxury homebuilder Toll Brothers reported better-than-expected second quarter earnings on increased demand for new homes.
You can't get away from the need for good yield in an era of commodity inflation.
Let's look at five holdings that stayed in his portfolio for at least a year.